Figure 1.

Early virologic response (EVR) and sustained virologic response (SVR) in patients retreated with PEG-IFN alpha 2b plus RBV according to the HCV genotypes (n = 104).

Gonçales et al. BMC Infectious Diseases 2010 10:212   doi:10.1186/1471-2334-10-212
Download authors' original image